SCHEMBL5507260

SCHEMBL5507260

[CH2]c1ccc(C(F)(F)P(=O)(O)OCCOC(=O)OC(C)C)c(Br)c1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 5/20 0.34
PTPN1 P18031 8/20 0.33
IDO1 P14902 3/20 0.32
PTPN5 P54829 1/20 0.30
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507258 0.82 PTPN1 (0.37) PTPN2PTPN1PTPN5NOTUM
SCHEMBL5507203 0.81 PTPN1 (0.33) PTPN2PTPN1IDO1
SCHEMBL5502478 0.76 PTPN2 (0.32) PTPN2PTPN1
SCHEMBL5266442 0.70
SCHEMBL5517356 0.70 PTPN2 (0.40) PTPN2PTPN1NOTUM
SCHEMBL7622217 0.70 PTPN1 (0.67) PTPN2PTPN1
SCHEMBL5499845 0.70 PTPN1 (0.51) PTPN2PTPN1
SCHEMBL14266790 0.70 PTPN1 (0.44) PTPN2PTPN1PTPN5NOTUM
SCHEMBL16343790 0.65 TSHR (0.33)
SCHEMBL13910219 0.65 PTPN1 (0.49) PTPN2PTPN1PTPN5NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786421-A2 OXYGEN/NITROGEN HETEROCYCLE INHIBITORS OF TYROSINE PHOSPHATASES Cengent Therapeutics, Inc. (US) 2007-05-23 EP claimed
WO-2006017124-A2 OXYGEN/NITROGEN HETEROCYCLE INHIBITORS OF TYROSINE PHOSPHATASES CENGENT THERAPEUTICS, INC. (US) 2006-02-16 WO claimed